Dermira Inc (DERM)
$19.15 0.00 (0.00%)
17:41 EST DERM Stock Quote Delayed 15 Minutes
Previous Close $19.15
Market Cap 801.39M
PE Ratio -2.36
Volume (Avg. Vol.)
Day's Range 19.15 - 19.15
52-Week Range 5.25 - 19.48
Dividend & Yield N/A (N/A)
DERM Stock Predictions, Articles, and Dermira Inc News
- From InvestorPlace
- From the Web
While you're going to the gym and starting a diet, why not make some investing resolutions? Try to avoid fad stocks and demand dividends.
Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?
Dermira news concerning positive results from a recent Phase 2b study of lebrikizumab has DERM stock flying high on Monday.
Dermira (DERM) stock is tanking today on news that its new acne drug is a failure and that it will likely stop its development.
10 Pharmaceuticals stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
The following stocks were moving the Manufacturing sector today.
3 Stocks to Watch on Thursday: Ciena Corporation (CIEN), Dermira Inc (DERM) and Joy Global Inc. (JOY)
Ciena (CIEN) and Joy Global (JOY) shoot higher on Street-beating results, while Dermira (DERM) is popping on positive trial news for its sweating treatment.
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Bearish investors can find an opportunity in these biotech stocks as they look to continue a downward trend.
From The Motley Fool
From Market News Video
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Dermira Inc (DERM), where a total of 13,093 contracts have traded so far, representing approximately 1.3 million underlying shares. That amounts to about 72.5% of DERM's average daily trading volume over the past month of 1.8 million shares..
Navellier RatingsPowered by Portfolio Grader